NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) was identified by our screener as a strong growth stock with a favorable technical setup. The company combines solid fundamentals with a promising price pattern, making it worth a closer look.
Fundamental Strengths
Growth Potential: NBIX has demonstrated strong revenue growth, with a 21.73% increase over the past year and a 24.48% average annual growth rate. Earnings are expected to grow by 35.48% annually in the coming years.
Profitability: The company scores an 8/10 in profitability, with high margins—12.68% net profit margin and 20.78% operating margin—placing it ahead of most peers in the biotechnology sector.
Financial Health: With no debt and a solid Altman-Z score of 8.12, NBIX maintains a strong balance sheet, earning a 7/10 health rating.
Technical Setup
Positive Trends: Both short-term and long-term trends are bullish, with the stock trading near the upper end of its recent range ($122.66 - $131.00).
Consolidation Breakout: Prices have been consolidating, suggesting a potential breakout. A key resistance zone lies between $129.12 and $129.41—a move above this level could signal further upside.
Support Levels: A strong support zone between $124.17 and $128.18 provides a cushion, reducing downside risk.
This is not investment advice. The observations here are based on current data, but market conditions can change. Always conduct your own research before making investment decisions.